This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Inflammatory bowel disease (IBD) refers to two disorders (Crohn's disease and ulcerative colitis) in which the gastrointestinal (GI) tract is inflamed for a long time. Inflammatory bowel disease (IBD) is a life-threatening gastroenteric inflammatory disease characterized by episodes of intestinal inflammation. IBD has a complicated pathogenesis. Long-term inflammation damages the gastrointestinal tract. IBD is a chronic disease that strikes both men and women at an early age. IBD's incidence and prevalence increased dramatically in the second half of the twentieth century, and IBD has been regarded as one of the most common gastrointestinal disorders in newly industrialized countries since the turn of the century.
Gastroesophageal reflux disease (GERD) affects about 20% of the adult population in high-income nations and is defined by recurrent and bothersome heartburn and regurgitation, as well as GERD-specific consequences. GERD is a condition marked by troubling symptoms and consequences caused by stomach contents refluxing into the oesophagus. GERD is often diagnosed based on classic symptoms and an empiric trial's response to acid suppression. GERD is a serious health problem because it is linked to a lower quality of life and a high rate of morbidity. While GERD drugs are not exceptionally expensive, the cost of treating GERD patients has been estimated to be two times that of non-GERD patients.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States